Urokinase 250000IU Injection
Marketer
TTK Healthcare Ltd
Salt Composition
Urokinase (250000IU)
Overview Urokinase 250000IU Injection
Urokinase 250,000 IU injection dissolves dangerous blood clots obstructing blood vessels. It aids in the recovery of individuals following a recent myocardial infarction. Further applications include treatment of pulmonary embolism and stroke. Administration requires strict medical oversight; dosage and treatment length are determined individually by a physician, who will monitor the patient's progress until stabilization. Potential side effects include nausea, vomiting, bleeding at the injection site, allergic responses, and hypotension. Increased bleeding risk is also possible. A physician will discuss both advantages and potential drawbacks before administering the injection. Concurrently prescribed medications should be continued as directed. Caution is advised for patients with bleeding disorders, renal or hepatic impairment; pregnancy, breastfeeding, and all other medications must be disclosed to the treating physician.
Uses of Urokinase 250000IU Injection
Myocardial infarction|Lung blood clot
Major Benefits of Urokinase 250000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Urokinase 250000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Urokinase 250000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Urokinase 250000IU Injection works:
Urokinase 250000IU Injection facilitates the breakdown of obstructive blood clots within the vascular system. This action re-establishes blood circulation to compromised tissue, mitigating tissue necrosis and enhancing patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Urokinase 250000IU Injection may pose safety risks; the interaction is currently unestablished. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of 250,000 IU Urokinase injections is typically deemed safe for pregnant individuals. Preclinical trials using animals have revealed minimal or no negative consequences for fetal development; nonetheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers may likely use Urokinase 250000IU Injection without significant risk to their infants. Available human data indicates minimal danger to the nursing baby.
DrivingNOT RELEVANT
Urokinase 250000IU Injection is exclusively administered in a hospital setting.
KidneySAFE IF PRESCRIBED
Administering 250,000 IU of Urokinase injection is likely safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary for this patient group. However, physician consultation is advised. Urokinase 250,000 IU injection is contraindicated in patients exhibiting severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should use Urokinase 250000IU Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Urokinase 250000IU Injection :
Omit a Urokinase 250000IU Injection dose? Seek your physician's advice.
Facts to Know About Urokinase 250000IU Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide and Amino Acid Analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Early Thrombolytic Agents |
3,018 People bought this recently